Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition
Journal of Reproductive Immunology · 2026-08 · 176 · 104931
DOI: 10.1016/j.jri.2026.104931 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Reproductive Immunology, 2026-08. Verfasst von Noémie Abisror und 5 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, Paris …. Hauptthemen laut MEDLINE: Abortion, Habitual, Placenta Diseases, Autoimmune Diseases, Immunotherapy. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Massive perivillous fibrinoid deposition (MPFD) is an extremely rare placental pathology associated with recurrent pregnancy loss and adverse perinatal outcomes. We present the case of a 41-year-old woman with systemic autoimmune disorders and a history of ten pregnancy losses, with histologically confirmed perivillous fibrinoid deposition in two available previous placental specimens and no evidence of chronic histiocytic intervillositis in the reviewed material. A personalized immunomodulatory protocol combining intravenous immunoglobulin (IVIg), corticosteroids, hydroxychloroquine, and antithrombotic therapy was associated with a successful full-term pregnancy, culminating in the live birth of a healthy infant by C-section. This case highlights the potential utility of tailored immunotherapy in complex recurrent pregnancy loss (RPL) cases associated with MPFD, although causal attribution to any single agent cannot be established given the single-case design, incomplete histological documentation of prior losses, and the simultaneous use of multiple interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, Paris F-75012, France.
- AP-HP, Hôpital Armand Trousseau, service d'Anatomie et Cytologie Pathologiques, Sorbonne Université, Paris F-75012, France.
- Service de Gynécologie-Obstétrique, CHR Metz Thionville, Metz, France.
- Médecine Interne, Hôpital Robert Schuman, Metz, France.
- AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, Paris F-75012, France. Electronic address: arsene.mekinian@aphp.fr.
Zitieren
APA
Abisror, N., Hermine, A. C., Dolenc, B., Ezsto, M. L., Campagne, J., & Mekinian, A. (2026). Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition. Journal of Reproductive Immunology, 176, 104931. https://doi.org/10.1016/j.jri.2026.104931
Vancouver
Abisror N, Hermine AC, Dolenc B, Ezsto ML, Campagne J, Mekinian A. Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition. Journal of Reproductive Immunology. 2026;176:104931. doi:10.1016/j.jri.2026.104931
BibTeX
@article{Abisror2026,
author = {Abisror, Noémie and Hermine, Aurore Coulomb and Dolenc, Bérangère and Ezsto, Marie-Laure and Campagne, Julien and Mekinian, Arsene},
title = {Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition},
journal = {Journal of Reproductive Immunology},
year = {2026},
volume = {176},
pages = {104931},
doi = {10.1016/j.jri.2026.104931}
}
EUVIMED